CINQAIR

Google image searchProduct monograph

Active ingredient

reslizumab, 10 MG/ML

DIN: 02456419

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: TEVA CANADA LIMITED

Date: 19-DEC-2016

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
• R03DX — Other systemic drugs for obstructive airway diseases (ATC, ATC/DDD)
• R03DX08 — RESLIZUMAB (ATC/DDD)

External Links for Cinqair

Search on Google

• Cinqair side effects
• Cinqair dosage
• reslizumab side effects
• reslizumab dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find cinqair photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.